British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

AstraZeneca has unveiled plans to invest £2bn in Beijing months after Chinese authorities detained the company’s local boss ...

The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

Foreign CEOs, including Tim Cook of Apple, as well as Republican Sen. Steve Daines are in Beijing for the two-day China ...

AstraZeneca has announced a $2.5bn investment in the company’s sixth worldwide strategic research and development (R&D) centre in Beijing, China. The initiative, which will take place up to 2029 ...

The pharmaceutical company said the investment in the research-and-development center in Beijing will bolster its footprint ...